No Picture
News

Sutro Biopharma Expands Senior Management Team with the Appointments of Vice President of Immunobiology and Vice President of Business Development

SOUTH SAN FRANCISCO, Calif., Feb. 5, 2020 /PRNewswire/ — Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to c… […]

No Picture
News

BioMarin Announces CFO Succession

Brian R. Mueller, Chief Accounting Officer and 17-year company veteran, named acting CFODan Spiegelman steps down as CFO; will assist with transition until September 1, 2020

SAN RAFAEL, Calif., Feb. 3, 2020 /PRNewswire/ — BioMarin Pharmaceutical Inc… […]

No Picture
News

Kyverna Therapeutics Secures $25 Million Series A Funding from Key Investors and Enters into Strategic Collaboration with Gilead Sciences

Collaboration Brings Together Gilead’s Commitment to Advancing Cell Therapy with Kyverna’s Focus on Advanced T Cell Engineering Targeting Autoimmune DiseasesSeries A Investors Include Vida Ventures, Westlake Village BioPartners and Gilead SciencesDomin… […]

No Picture
News

Bolt Biotherapeutics Expands Scientific Advisory Board with Appointment of Dr. Priti Hegde

– Dr. Hegde Brings Cancer Immunotherapy Drug Development Expertise to Bolt as Company Advances Lead Program Toward First Clinical Study –

REDWOOD CITY, Calif., Jan. 9, 2020 /PRNewswire/ — Bolt Biotherapeutics, Inc., a private biotechnology company … […]

No Picture
News

Eiger BioPharmaceuticals Appoints Industry Veteran Eldon Mayer as Executive Vice President and Chief Commercial Officer

– Launch Preparation Underway for Lonafarnib in Progeria- Market Development Activities Advancing for HDV Program

PALO ALTO, Calif., Jan. 7, 2020 /PRNewswire/ — Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), a late-stage clinical biopharmaceutical… […]